Biotoxtech is South Korea’s leading non-clinical CRO (Contract Research Organization), specializing in preclinical toxicology studies for the evaluation of drug safety and efficacy. Backed by globally recognized GLP certifications, Biotoxtech delivers precise research and reliable results, effectively supporting clients in their drug development journey. Through continuous research and technological advancement, Biotoxtech has established itself as a trusted partner for pharmaceutical and biotech companies worldwide.

Keyprime Research operates South Korea’s largest primate-based non-clinical testing facility, offering premium safety and efficacy testing services. Equipped with global GLP certifications and state-of-the-art equipment, it conducts essential studies for the development of next-generation biologics and innovative therapeutics. By providing tailored services and groundbreaking research, Keyprime Research leads scientific discovery and has solidified its reputation as a reliable research institution in the global market.

Keyfron Bio is a leading specialist CRO in bioanalytical services and ADME (Absorption, Distribution, Metabolism, and Excretion) studies. It develops highly sensitive and accurate analytical methods for a wide range of drug candidates, including antibodies, proteins, and gene therapies, along with GLP-compliant validation services. Leveraging differentiated technology and extensive expertise, Keyfron Bio is a partner committed to accelerating and streamlining its clients’ drug development processes.

Founded in 2021 – GLP certification in 2023 – Accreditation in 2024